Tag: 普陀体验上海黑玫瑰

  • United States Melanoma Market Report 2021: Epidemiology, Valuations and Forecast, Drugs Sales and Competitive…

    first_img TAGS  By Digital AIM Web Support – February 11, 2021 United States Melanoma Market Report 2021: Epidemiology, Valuations and Forecast, Drugs Sales and Competitive Landscape 2017-2026 – ResearchAndMarkets.com Pinterest DUBLIN–(BUSINESS WIRE)–Feb 11, 2021– The “US Melanoma Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. US Melanoma Market and Competitive Landscape Highlights – 2021, provides comprehensive insights into Melanoma pipeline products, Melanoma epidemiology, Melanoma market valuations and forecast, Melanoma drugs sales and competitive landscape in the US. The research is classified into seven sections – Melanoma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares. Research Scope:Melanoma pipeline: Find out the products in clinical trials for the treatment of Melanoma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the productsMelanoma epidemiology: Find out the number of patients diagnosed (prevalence) with Melanoma in the USMelanoma drugs: Identify key products marketed and prescribed for Melanoma in the US, including trade name, molecule name, and companyMelanoma drugs sales: Find out the sales revenues of Melanoma drugs in the USMelanoma market valuations: Find out the market size for Melanoma drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026Melanoma drugs market share: Find out the market shares for key Melanoma drugs in the US Benefits of this Research:Support monitoring and reporting national Melanoma market analysis and sales trendsTrack competitor drugs sales and market share in the US Melanoma marketTrack competitive developments in Melanoma market and present key issues and learningsSynthesize insights for Melanoma market and products to drive business performanceAnswer key business questions about the Melanoma marketEvaluate commercial market opportunity assessment, positioning, and segmentation for Melanoma productsSupports decision making in R&D to long term marketing strategies Key Topics Covered: 1) Melanoma Treatments 2) Melanoma Pipeline 3) US Melanoma Epidemiology 4) Marketed Drugs for Melanoma in US 5) US Melanoma Market Size and Forecast 6) US Melanoma Products Sales and Forecast 7) US Melanoma Market Competitive Landscape 8) Methodology For more information about this report visit https://www.researchandmarkets.com/r/a5gaq6 View source version on businesswire.com:https://www.businesswire.com/news/home/20210211005732/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/11/2021 12:07 PM/DISC: 02/11/2021 12:07 PM http://www.businesswire.com/news/home/20210211005732/en Twitter WhatsApp Facebookcenter_img Twitter WhatsApp Local NewsBusiness Pinterest Facebook Previous articleDriver who plunged off Wisconsin ramp thankful to be aliveNext articleEmotional Investing And Social Media Digital AIM Web Supportlast_img read more

  • $100 is too much for borrowers

    first_imgThe majority of Queensland borrowers can only bear a small change in interest rates before they are tipped into mortgage stress.Comparison website Finder.com.au have released survey results showing 55 per cent of Queensland mortgage holders would be financial stressed if home loan repayments rose by just $100 per month.Finder said this is equivalent to an increase in the average home loan rate of 0.45 per cent based on the national average mortgage of $360,600.The result was mirrored across other states with New South Wales, Tasmania and Western Australian all recording 59 per cent of mortgage holders would struggle to find the extra $100 per month.In South Australia, a whopping 71 per cent of mortgage holders would struggle to deal with the increase.More from newsMould, age, not enough to stop 17 bidders fighting for this home6 hours agoBuyers ‘crazy’ not to take govt freebies, says 28-yr-old investor6 hours agoBessie Hassan, a money expert at Finder, said the results show many borrowers have overextended.“The typical mortgage holder would be in trouble when interest rates got back up around 5.28 per cent,” she said.“That’s a pretty small window before borrowing costs start to hurt.”Ms Hassan said some owner occupiers were getting into huge housing debt at record low interest rates, but it wouldn’t take much to be in the red.She said given major lenders have already announced out-of-cycle interest rate increases, borrowers at their limit need to consider their options.“The reality is borrowers have overextended themselves if it only takes a $100 leap in repayments for more than half of all homeowners to reach their tipping point.”last_img read more